Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline as Adjunctive Therapy in Ulcerative Colitis
NCT05575505Phase 2Completed
- Sponsor
- Tanta University
- Start
- Feb 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in ulcerative colitis (UC), sponsored by Tanta University. Started Feb 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05575505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575505.